story of the week
Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-Related Macular Degeneration
Am J Ophthalmol 2018 Apr 12;[EPub Ahead of Print], PJ Rosenfeld, MA Windsor, WJ Feuer, SJJ Sun, KD Frick, EA Swanson, D HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.